BO

Blue Owl Capital Holdings LP

Diversified strategySector-focusedMomentum follower

Total reported value

$372.2M

Reporting period: 2026-03-31 · Number of holdings: 76

Blue Owl Capital Holdings LP disclosed 76 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $372.2M and a quarterly turnover rate of 60.7%.

Personality snowflake

Concentration
25.18
Portfolio Stability
60.71
Momentum/Contrarian
100
Sector conviction
100
Diversification
100
Sizing Uniformity
80.58

Recent moves

  • Add MPLT

    +207.6%　$14.7M

  • Trim OBDC

    0.0%　-$3.5M

  • Trim SGMT

    -73.2%　-$5.6M

  • Trim HLLY

    +2.2%　-$4.1M

  • Trim CMPX

    -15.1%　-$3.1M

  • Trim NCDL

    0.0%　-$1.3M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 75 holdings (of 76 total)

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1AKTSAktis Oncology INCStock-Other15.20%+15.20%NEW
2LRMRLarimar Therapeutics INCStock-Other8.61%+0.59%+4.34%
3✓ Engene Holdings INCStock-Other8.08%-1.29%+31.40%
4NCDLNuveen Churchill Direct LendStock-Other7.33%-1.49%—
5CGEMCullinan Therapeutics INCStock-Other7.29%-0.22%-18.77%
6OBDCBlue Owl Capital CORPStock-Financials6.08%-1.98%—
7MPLTMaplight Therapeutics INCStock-Other5.49%+3.72%+207.57%
8CMPXCompass Therapeutics INCStock-Other4.18%-1.56%-15.14%
9CNTXContext Therapeutics INCStock-Other3.58%+0.21%-31.53%
10HLLYHolley INCStock-Other3.49%-1.80%+2.18%
11EYPTEyepoint INCStock-Other3.16%+0.95%+132.45%
12CRVSCorvus Pharmaceuticals INCStock-Other2.14%+2.14%NEW
13CNDTConduent INCStock-Other1.73%-1.13%+4.44%
14RAREUltragenyx Pharmaceutical InStock-Other1.70%+0.19%+42.33%
15AQSTAquestive Therapeutics INCStock-Other1.50%+0.45%+156.75%
16RYTMRhythm Pharmaceuticals INCStock-Other1.44%+1.44%NEW
17✓ Compass Pathways PLCStock-Other1.38%+1.38%NEW
18IMMXImmix Biopharma INCStock-Other1.34%—-44.48%
19IMAImagenebio INCStock-Other1.29%-0.46%+16.45%
20CVEOCiveo CORPStock-Other1.28%-1.34%-51.29%
21LENZLenz Therapeutics INCStock-Other1.25%+0.51%+237.81%
22ELDNEledon Pharmaceuticals INCStock-Other1.18%+0.28%-26.43%
234XC1Kalvista Pharmaceuticals INCStock-Other1.16%-0.63%-40.28%
24OVIDOvid Therapeutics INCStock-Other1.14%+1.14%NEW
25PVLAPalvella Therapeutics INCStock-Other1.05%-0.25%-22.36%
26PLRXPliant Therapeutics INCStock-Other1.01%——
27STWDStarwood Property Trust INCStock-Real Estate0.73%+0.73%NEW
28✓ Adc Therapeutics SAStock-Other0.70%-0.21%—
29EVMNEvommune INCStock-Other0.62%+0.62%NEW
30DELLDell Technologies -cStock-Tech0.61%-1.48%-74.19%
31✓ Larimar Therapeutics INCStock-Other0.51%+0.51%NEW
32ORICOric Pharmaceuticals INCStock-Other0.51%-0.79%-70.87%
33SGMTSagimet Biosciences Inc-aStock-Other0.47%-1.80%-73.16%
34WWWw International Inc-newStock-Other0.35%+0.35%NEW
35✓ Engene Holdings INCStock-Other0.35%+0.32%+1316.00%
36EPDEnterprise Products PartnersStock-Energy0.32%——
37FLDFold Holdings INCStock-Other0.30%——
38OPTXWOmnilit Acquisition Cl A -23Stock-Other0.23%+0.17%—
39MRKRMarker Therapeutics INCStock-Other0.19%——
40✓ Mineralys Therapeutics INCStock-Other0.16%+0.16%NEW
41NIOBWNiocorp Developments LTD -28Stock-Other0.14%-0.37%-63.47%
42✓ Compass Therapeutics INCStock-Other0.13%+0.13%NEW
43BNAIWBrand Engagement Netwo -cw27Stock-Other0.11%+0.08%-38.86%
44CAHCardinal Health INCStock-Healthcare0.10%——
45✓ Rezolve Ai LTDStock-Other0.05%—-18.73%
46PIPRPiper Sandler CosStock-Financials0.05%——
47✓ Alpha Modus Hldgs INCStock-Other0.04%——
48ETEnergy Transfer LPStock-Energy0.03%——
49✓ Stock-Other0.03%——
50CAICaris Life Sciences INCStock-Other0.02%——
1–50 of 75

Holding changes this quarter

Blue Owl Capital Holdings LP's most significant position changes for 2026-03-31: New buy: Aktis Oncology INC (AKTS); Sold out: Repare Therapeutics INC (RPTX); New buy: Corvus Pharmaceuticals INC (CRVS); Sold out: Procore Technologies INC (PCOR); Sold out: Roivant Sciences Ltd. (ROIV).

Position changes disclosed by Blue Owl Capital Holdings LP for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1MPLTMaplight Therapeutics INC+3.7%+207.57%Add
2EYPTEyepoint INC+1%+132.45%Add
3LRMRLarimar Therapeutics INC+0.6%+4.34%Add
4LENZLenz Therapeutics INC+0.5%+237.81%Add
5AQSTAquestive Therapeutics INC+0.5%+156.75%Add
6✓ Engene Holdings INC+0.3%+1316.00%Add
7ELDNEledon Pharmaceuticals INC+0.3%-26.43%Trim
8CNTXContext Therapeutics INC+0.2%-31.53%Trim
9RAREUltragenyx Pharmaceutical In+0.2%+42.33%Add
10OPTXWOmnilit Acquisition Cl A -23+0.2%—Unchanged
11BNAIWBrand Engagement Netwo -cw27+0.1%-38.86%Trim
12✓ Adc Therapeutics SA-0.2%—Unchanged
13CGEMCullinan Therapeutics INC-0.2%-18.77%Trim
14PVLAPalvella Therapeutics INC-0.3%-22.36%Trim
15NIOBWNiocorp Developments LTD -28-0.4%-63.47%Trim
16IMAImagenebio INC-0.5%+16.45%Add
174XC1Kalvista Pharmaceuticals INC-0.6%-40.28%Trim
18ORICOric Pharmaceuticals INC-0.8%-70.87%Trim
19CNDTConduent INC-1.1%+4.44%Add
20✓ Engene Holdings INC-1.3%+31.40%Add
21CVEOCiveo CORP-1.3%-51.29%Trim
22DELLDell Technologies -c-1.5%-74.19%Trim
23NCDLNuveen Churchill Direct Lend-1.5%—Unchanged
24CMPXCompass Therapeutics INC-1.6%-15.14%Trim
25SGMTSagimet Biosciences Inc-a-1.8%-73.16%Trim
26HLLYHolley INC-1.8%+2.18%Add
27OBDCBlue Owl Capital CORP-2%—Unchanged
28AKTSAktis Oncology INC—NEWNew buy
29RPTXRepare Therapeutics INC—EXITSold out
30CRVSCorvus Pharmaceuticals INC—NEWNew buy
31PCORProcore Technologies INC—EXITSold out
32ROIVRoivant Sciences Ltd.—EXITSold out
33RYTMRhythm Pharmaceuticals INC—NEWNew buy
34✓ Compass Pathways PLC—NEWNew buy
35IMRXImmuneering CORP - Class A—EXITSold out
36OVIDOvid Therapeutics INC—NEWNew buy
37PAYOPayoneer Global INC—EXITSold out
38260Centessa Pharmaceuticals-adr—EXITSold out
39CMPSCompass Pathways PLC—EXITSold out
40NUNu Holdings Ltd.—EXITSold out
41STWDStarwood Property Trust INC—NEWNew buy
42MLYSMineralys Therapeutics INC—EXITSold out
43EVMNEvommune INC—NEWNew buy
44✓ Larimar Therapeutics INC—NEWNew buy
45JANXJanux Therapeutics INC—EXITSold out
46WWWw International Inc-new—NEWNew buy
47CHYMChime Financial Inc-cl A—EXITSold out
48✓ Mineralys Therapeutics INC—NEWNew buy
49✓ Compass Therapeutics INC—NEWNew buy
50✓ Alpha Tau Medical LTD—EXITSold out

FAQ

What is Blue Owl Capital Holdings LP and what type of investor is it?
Blue Owl Capital Holdings LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $372.2M, spread across 76 disclosed positions.
What are Blue Owl Capital Holdings LP's largest equity positions?
Based on the latest 13F filing, Blue Owl Capital Holdings LP's top holdings by market value are: 1. Aktis Oncology INC (AKTS) — $56.6M (15.2%) 2. Larimar Therapeutics INC (LRMR) — $32.0M (8.6%) 3. Engene Holdings INC — $30.1M (8.1%) 4. Nuveen Churchill Direct Lend (NCDL) — $27.3M (7.3%) 5. Cullinan Therapeutics INC (CGEM) — $27.1M (7.3%)
What changes did Blue Owl Capital Holdings LP make in its most recent portfolio filing?
In the latest reported quarter, Blue Owl Capital Holdings LP made 46 notable position adjustments: 11 new positions were initiated, 11 existing holdings were added to, 12 positions were partially reduced, and 12 were completely exited. The largest of these moves: New buy: Aktis Oncology INC (AKTS); Sold out: Repare Therapeutics INC (RPTX); New buy: Corvus Pharmaceuticals INC (CRVS); Sold out: Procore Technologies INC (PCOR); Sold out: Roivant Sciences Ltd. (ROIV)
What sectors does Blue Owl Capital Holdings LP focus on?
Blue Owl Capital Holdings LP is concentrated in the following sectors based on its current disclosed equity portfolio: • Financials: 77.4% • Real Estate: 9.3% • Information Technology: 7.7% • Energy: 4.4% • Health Care: 1.2%